Attenbio

Attenbio is a technology company specialized in the development of Point of Care (POC) in vitro diagnostic systems, capable of delivering fast, accurate, and accessible results. Their mission is to address unmet diagnostic needs through an innovative platform based on graphene biosensors and nanoelectronic technology.

These biosensors detect multiple biomarkers (viruses, bacteria, DNA, proteins) from non-invasive samples such as saliva, urine, or swabs. They achieve sensitivity and specificity levels above 95%, comparable to PCR tests but with the simplicity, speed, and low cost of immunoassays.

Attenbio’s technology combines advanced biotechnology, precision electronics, and scalable processes to develop compact, automated devices ready for deployment in hospitals, health centers, pharmacies, and other healthcare settings.

Their goal is to transform the traditional diagnostic model by facilitating access to reliable and efficient tests that enhance the healthcare system’s response capacity to current and future clinical challenges.